These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2959487

  • 1. The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino)chroman.
    Cossery JM, Gozlan H, Spampinato U, Perdicakis C, Guillaumet G, Pichat L, Hamon M.
    Eur J Pharmacol; 1987 Aug 11; 140(2):143-55. PubMed ID: 2959487
    [Abstract] [Full Text] [Related]

  • 2. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
    Hall MD, Gozlan H, Emerit MB, el Mestikawy S, Pichat L, Hamon M.
    Neurochem Res; 1986 Jun 11; 11(6):891-912. PubMed ID: 3016581
    [Abstract] [Full Text] [Related]

  • 3. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.
    Alexander BS, Wood MD.
    J Pharm Pharmacol; 1988 Dec 11; 40(12):888-91. PubMed ID: 2907586
    [Abstract] [Full Text] [Related]

  • 4. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M.
    Eur J Pharmacol; 1995 Jan 16; 288(2):173-86. PubMed ID: 7720779
    [Abstract] [Full Text] [Related]

  • 5. Photoaffinity labelling and solubilization on the central 5-HT1A receptor binding site.
    Gozlan H, Emerit MB, el Mestikawy S, Cossery JM, Marquet A, Besselievre R, Hamon M.
    J Recept Res; 1987 Jan 16; 7(1-4):195-221. PubMed ID: 2957498
    [Abstract] [Full Text] [Related]

  • 6. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D, Engel G, Kalkman HO.
    Eur J Pharmacol; 1985 Nov 26; 118(1-2):13-23. PubMed ID: 2935410
    [Abstract] [Full Text] [Related]

  • 7. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW, Asarch KB, Shih JC.
    J Neurochem; 1986 Jan 26; 46(1):68-75. PubMed ID: 2933490
    [Abstract] [Full Text] [Related]

  • 8. Decreased 5-hydroxytryptamine turnover in striatum and other brain regions after administration of 5-methoxy-3-(di-n-propylamino)chroman to rats.
    Fuller RW, Perry KW, Ward JS.
    J Pharm Pharmacol; 1989 Nov 26; 41(11):805-6. PubMed ID: 2576058
    [Abstract] [Full Text] [Related]

  • 9. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
    Gozlan H, Ponchant M, Daval G, Verge D, Menard F, Vanhove A, Beaucourt JP, Hamon M.
    J Pharmacol Exp Ther; 1988 Feb 26; 244(2):751-9. PubMed ID: 2964524
    [Abstract] [Full Text] [Related]

  • 10. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
    Naiman N, Lyon RA, Bullock AE, Rydelek LT, Titeler M, Glennon RA.
    J Med Chem; 1989 Jan 26; 32(1):253-6. PubMed ID: 2521252
    [Abstract] [Full Text] [Related]

  • 11. Further characterisation of [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding sites in human brain postmortem.
    Palego L, Marazziti D, Rotondo A, Batistini A, Lucacchini A, Naccarato AG, Bevilacqua G, Borsini F, Ladinsky H, Cassano GB.
    Neurochem Int; 1997 Feb 26; 30(2):149-57. PubMed ID: 9017662
    [Abstract] [Full Text] [Related]

  • 12. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
    Hall MD, el Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H.
    J Neurochem; 1985 Jun 26; 44(6):1685-96. PubMed ID: 3157780
    [Abstract] [Full Text] [Related]

  • 13. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ, Haj-Dahmane S, Jolas T, Lanfumey L, Fattaccini CM, Guardiola-Lemaitre B, Gozlan H, Hamon M.
    J Pharmacol Exp Ther; 1993 Feb 26; 264(2):863-72. PubMed ID: 8094756
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
    Yokota N, Yamawaki S, Hayakawa H, Yoshida R, Sarai K.
    Yakubutsu Seishin Kodo; 1989 Jun 26; 9(2):197-206. PubMed ID: 2530729
    [Abstract] [Full Text] [Related]

  • 17. Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat.
    Burnet PW, Mefford IN, Smith CC, Gold PW, Sternberg EM.
    J Neurochem; 1992 Sep 26; 59(3):1062-70. PubMed ID: 1379629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies.
    Laporte AM, Schechter LE, Bolaños FJ, Vergé D, Hamon M, Gozlan H.
    Eur J Pharmacol; 1991 May 30; 198(1):59-67. PubMed ID: 1680714
    [Abstract] [Full Text] [Related]

  • 20. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
    Hamon M, Bourgoin S, Gozlan H, Hall MD, Goetz C, Artaud F, Horn AS.
    Eur J Pharmacol; 1984 May 04; 100(3-4):263-76. PubMed ID: 6203761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.